Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
122.85
+1.78 (1.47%)
May 21, 2024, 4:00 PM EDT - Market closed

Ascendis Pharma Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Ascendis Pharma stock have an average target of 173.88, with a low estimate of 89 and a high estimate of 262. The average target predicts an increase of 41.54% from the current stock price of 122.85.

Analyst Consensus: Buy
Target Low Average Median High
Price $89 $173.88 $173 $262
Change -27.55% +41.54% +40.82% +113.27%

Analyst Ratings

The average analyst rating for ASND stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 333322
Buy 443344
Hold 333322
Sell 000000
Strong Sell 000000
Total 10109988

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Morgan Stanley
Morgan Stanley
Hold
Maintains
$116$140
Hold Maintains $116$140 +13.96% May 16, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$173
Buy Reiterates $173 +40.82% May 15, 2024
Wells Fargo
Wells Fargo
Buy
Maintains
$260$262
Buy Maintains $260$262 +113.27% May 3, 2024
JP Morgan
JP Morgan
Buy
Maintains
$167$170
Buy Maintains $167$170 +38.38% May 3, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$173
Buy Reiterates $173 +40.82% May 3, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
440.73M
from 266.72M
Increased by 65.24%
Revenue Next Year
752.51M
from 440.73M
Increased by 70.74%
EPS This Year
-4.60
from -8.55
EPS Next Year
-0.37
from -4.60
Year 2019202020212022202320242025202620272028
Revenue
13.38M6.95M7.78M51.17M266.72M440.73M752.51M1.22B2.02B2.80B
Revenue Growth
26.41%-48.01%11.87%557.93%421.20%65.24%70.74%61.59%65.95%38.70%
EPS
-4.69-8.28-7.00-10.40-8.55-4.60-0.373.9216.7924.33
EPS Growth
--------328.51%44.95%
No. Analysts -----15151266
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 516.0M 1.0B 1.9B 2.8B 3.6B
Avg 440.7M 752.5M 1.2B 2.0B 2.8B
Low 373.4M 616.0M 869.6M 1.3B 1.6B

Revenue Growth

Revenue Growth 20242025202620272028
High
93.5%
127.4%
158.7%
130.5%
80.4%
Avg
65.2%
70.7%
61.6%
66.0%
38.7%
Low
40.0%
39.8%
15.6%
7.2%
-19.9%

EPS Forecast

EPS 20242025202620272028
High -2.67 4.49 9.07 26.76 37.46
Avg -4.60 -0.37 3.92 16.79 24.33
Low -6.44 -2.90 0.60 5.93 9.49

EPS Growth

EPS Growth 20242025202620272028
High - - -
583.2%
123.1%
Avg - - -
328.5%
44.9%
Low - - -
51.5%
-43.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.